Testing effectiveness (Phase 2)Active Not RecruitingNCT02911142
What this trial is testing
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
Who this might be right for
Primary Effusion LymphomaB-Cell Neoplasm
National Cancer Institute (NCI) 17